232 related articles for article (PubMed ID: 25488809)
1. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
[TBL] [Abstract][Full Text] [Related]
2. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
3. KDM4B is a master regulator of the estrogen receptor signalling cascade.
Gaughan L; Stockley J; Coffey K; O'Neill D; Jones DL; Wade M; Wright J; Moore M; Tse S; Rogerson L; Robson CN
Nucleic Acids Res; 2013 Aug; 41(14):6892-904. PubMed ID: 23723241
[TBL] [Abstract][Full Text] [Related]
4. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
5. The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer.
Jones D; Wilson L; Thomas H; Gaughan L; Wade MA
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31390833
[TBL] [Abstract][Full Text] [Related]
6. ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
Mahajan K; Lawrence HR; Lawrence NJ; Mahajan NP
J Biol Chem; 2014 Oct; 289(41):28179-91. PubMed ID: 25148682
[TBL] [Abstract][Full Text] [Related]
7. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
[TBL] [Abstract][Full Text] [Related]
8. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
[TBL] [Abstract][Full Text] [Related]
10. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
11. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.
Pedanou VE; Gobeil S; Tabariès S; Simone TM; Zhu LJ; Siegel PM; Green MR
Elife; 2016 Jul; 5():. PubMed ID: 27472901
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
13. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock.
Cheng MB; Zhang Y; Cao CY; Zhang WL; Zhang Y; Shen YF
PLoS Biol; 2014 Dec; 12(12):e1002026. PubMed ID: 25535969
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer.
Wang HY; Long QY; Tang SB; Xiao Q; Gao C; Zhao QY; Li QL; Ye M; Zhang L; Li LY; Wu M
Nucleic Acids Res; 2019 Mar; 47(5):2349-2364. PubMed ID: 30649550
[TBL] [Abstract][Full Text] [Related]
15. [Knockdown of lysine-specific demethylase 3A (KDM3A) inhibits the invasion and migration of MDA-MB-231 breast cancer cells and arrests the cell cycle in the G0/G1 phase].
Gao W; Zhang T; Yao J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):808-814. PubMed ID: 34533128
[TBL] [Abstract][Full Text] [Related]
16. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
[TBL] [Abstract][Full Text] [Related]
17. Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.
Fan L; Sudeep K; Qi J
Adv Exp Med Biol; 2023; 1433():69-86. PubMed ID: 37751136
[TBL] [Abstract][Full Text] [Related]
18. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
[TBL] [Abstract][Full Text] [Related]
20. The histone demethylase Kdm3a is essential to progression through differentiation.
Herzog M; Josseaux E; Dedeurwaerder S; Calonne E; Volkmar M; Fuks F
Nucleic Acids Res; 2012 Aug; 40(15):7219-32. PubMed ID: 22581778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
